Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vosaroxin in Elderly Untreated AML
NCT00607997Phase 2Completed
- Sponsor
- Sunesis Pharmaceuticals, Inc.
- Start
- May 2008
- Primary completion
- Nov 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of vosaroxin in acute myeloid leukemia (AML), sponsored by Sunesis Pharmaceuticals, Inc.. Started May 2008; status: completed.
02
Drugs
vosaroxin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00607997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00607997.